Patents by Inventor Peteris Prusis

Peteris Prusis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACOLOGICALLY ACTIVE QUINAZOLINEDIONE DERIVATIVES
    Publication number: 20170137387
    Abstract: Compounds of formula (I), wherein R1 through R8 are as defined in the claims, exhibit a positive allosteric GABAB modulator effect and are thus useful as positive allosteric modulators of the GABAB receptor.
    Type: Application
    Filed: May 8, 2015
    Publication date: May 18, 2017
    Inventors: Peteris PRUSIS, Iisa HÖGLUND, Olli TÖRMAKANGAS, Ari HIETANEN, Riina ARVELA, Anniina VESALAINEN, Terhi HEIKKINEN
  • N-prop-2-ynyl carboxamide derivatives and their use as TRPA1 antagonists
    Patent number: 9533952
    Abstract: Compounds of formula I, wherein A, B, X, Z and R1-R6, are as defined in the claims, exhibit TRPA 1 activity and are thus useful as TRPA1 modulators.
    Type: Grant
    Filed: September 30, 2013
    Date of Patent: January 3, 2017
    Assignee: ORION CORPORATION
    Inventors: Riina Arvela, Terhi Heikkinen, Patrik Holm, Peteris Prusis, Mattias Roslund, Harri Salo
  • N-PROP-2-YNYL CARBOXAMIDE DERIVATIVES AND THEIR USE AS TRPA1 ANTAGONISTS
    Publication number: 20150376130
    Abstract: Compounds of formula I, wherein A, B, X, Z and R1-R6, are as defined in the claims, exhibit TRPA 1 activity and are thus useful as TRPA1 modulators.
    Type: Application
    Filed: September 30, 2013
    Publication date: December 31, 2015
    Applicant: Orlon Corporation
    Inventors: Riina ARVELA, Terhi HEIKKINEN, Patrik HOLM, Peteris PRUSIS, Mattias ROSLUND, Harri SALO
  • Use of hydroxyguanidines
    Patent number: 6599943
    Abstract: The invention features pharmaceutical compositions that include hydroxyguanidines. The compositions can be used, for example, for treating or preventing ischemic diseases, hypoxia,or arrhythmias.
    Type: Grant
    Filed: May 26, 1999
    Date of Patent: July 29, 2003
    Assignee: WaPharm AB
    Inventors: Jarl Wikberg, Peteris Prusis, Maija Dambrova, Staffan Uhlén